The introduction of generic substitution and reference pricing has received widespread media attention. However, little attention has been paid to new regulated duties to be imposed on prescribers, including medical practitioners, registered dentists, nurses and midwives. These prescribers may face disciplinary hearings before their regulatory bodies, if they do not comply with their new obligations. Under the proposed new system, when a prescriber believes there are clinical reasons to prescribe a branded medicine, and not to substitute it for a cheaper equivalent, he / she must write "do not substitute" on the prescription to stop the pharmacist from dispensing the cheaper product. It is envisaged under the Bill that the Minister for Health may make secondary regulations requiring prescribers to specify what his / her "clinical reasons" are for prescribing the branded product. These regulations will be given force by broadening the scope of regulatory bodies, including the Medical...
Health (Pricing Of Medical Goods) Bill, 2012 - New Regulated Duties For Prescribers
|Author:||Mr Tom Hayes and Rebecca Ryan|
To continue readingREQUEST YOUR TRIAL